The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages
Open accessAbstract
Macrophages in atherosclerotic plaques drive inflammatory responses, degrade lipoproteins, and phagocytose dead cells. MicroRNAs (miRs) control the differentiation and activity of macrophages by regulating the signaling of key transcription factors. However, the functional role of macrophage-related miRs in the immune response during atherogenesis is unknown. Here, we report that miR-155 is specifically expressed in atherosclerotic plaques and proinflammatory macrophages, where it was induced by treatment with mildly oxidized LDL (moxLDL) and IFN-γ. Leukocyte-specific Mir155 deficiency reduced plaque size and number of lesional macrophages after partial carotid ligation in atherosclerotic (Apoe-/-) mice. In macrophages stimulated with moxLDL/IFN-γ in vitro, and in lesional macrophages, loss of Mir155 reduced the expression of the chemokine CCL2, which promotes the recruitment of monocytes to atherosclerotic plaques. Additionally, we found that miR-155 directly repressed expression of BCL6, a transcription factor that attenuates proinflammatory NF-κB signaling. Silencing of Bcl6 in mice harboring Mir155-/- macrophages enhanced plaque formation and CCL2 expression. Taken together, these data demonstrated that miR-155 plays a key role in atherogenic programming of macrophages to sustain and enhance vascular inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
Atherosclerosis: current pathogenesis and therapeutic options
Weber, C., & Noels, H. (2011) · Nature Medicine · doi:10.1038/nm.2538 · Cited by 2,203
Self-citationMicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Physiological and pathological roles for microRNAs in the immune system
O'Connell, R. M., Rao, D. S., Chaudhuri, A. A., & Baltimore, D. (2010) · Nature Reviews Immunology · doi:10.1038/nri2708 · Cited by 1,378
Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019
MicroRNAs: the fine-tuners of Toll-like receptor signalling
O'Neill, L. A., Sheedy, F. J., & McCoy, C. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2957 · Cited by 856
miR-155 gene: A typical multifunctional microRNA
Faraoni, I., Antonetti, F. R., Cardone, J., & Bonmassar, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.013 · Cited by 815 · cited 1×
“Several targets for miR-155 have been described in macrophages, including Socs1 and Sfpi1 , which regulate inflammatory and developmental processes, respectively (33, 45).”
Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis
Drechsler, M., Megens, R. T. A., van Zandvoort, M., Weber, C., & Soehnlein, O. (2010) · Circulation · doi:10.1161/circulationaha.110.961714 · Cited by 698
Self-citationRayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57275 · Cited by 690 · cited 1×
“In addition, miR-33 promotes the progression of atherosclerosis and impairs ABCA1-dependent cholesterol removal from lesional macrophages (40).”
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis
Kurowska-Stolarska, M., Alivernini, S., Ballantine, L. E., Asquith, D. L., Millar, N. L., Gilchrist, D. S., Reilly, J., Ierna, M., Fraser, A. R., Stolarski, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019536108 · Cited by 641
Björkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T., et al. (2004) · Nature Medicine · doi:10.1038/nm1008 · Cited by 634
Ceppi, M., Pereira, P. M., Dunand-Sauthier, I., Barras, E., Reith, W., Santos, M. A., & Pierre, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811073106 · Cited by 631
Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization
Arranz, A., Doxaki, C., Vergadi, E., Martinez de la Torre, Y., Vaporidi, K., Lagoudaki, E. D., Ieronymaki, E., Androulidaki, A., Venihaki, M., Margioris, A. N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119038109 · Cited by 608
The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAs
Androulidaki, A., Iliopoulos, D., Arranz, A., Doxaki, C., Schworer, S., Zacharioudaki, V., Margioris, A. N., Tsichlis, P. N., & Tsatsanis, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.024 · Cited by 581
Nam, D., Ni, C.-W., Rezvan, A., Suo, J., Budzyn, K., Llanos, A., Harrison, D., Giddens, D., & Jo, H. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00510.2009 · Cited by 492
Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice
Aiello, R. J., Bourassa, P.-A. K., Lindsey, S., Weng, W., Natoli, E., Rollins, B. J., & Milos, P. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.6.1518 · Cited by 466
Raitoharju, E., Lyytikäinen, L.-P., Levula, M., Oksala, N., Mennander, A., Tarkka, M., Klopp, N., Illig, T., Kähönen, M., Karhunen, P. J., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.020 · Cited by 448
Liu, G., Friggeri, A., Yang, Y., Park, Y.-J., Tsuruta, Y., & Abraham, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901216106 · Cited by 438
Welch, J. S., Ricote, M., Akiyama, T. E., Gonzalez, F. J., & Glass, C. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031789100 · Cited by 429
Li, Y., Schwabe, R. F., DeVries-Seimon, T., Yao, P. M., Gerbod-Giannone, M.-C., Tall, A. R., Davis, R. J., Flavell, R., Brenner, D. A., & Tabas, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501759200 · Cited by 421
Inflammation Impairs Reverse Cholesterol Transport In Vivo
McGillicuddy, F. C., de la Llera Moya, M., Hinkle, C. C., Joshi, M. R., Chiquoine, E. H., Billheimer, J. T., Rothblat, G. H., & Reilly, M. P. (2009) · Circulation · doi:10.1161/circulationaha.108.810721 · Cited by 391
Identifying Functional MicroRNAs in Macrophages with Polarized Phenotypes
Graff, J. W., Dickson, A. M., Clay, G., McCaffrey, A. P., & Wilson, M. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327031 · Cited by 367 · cited 10×
“Our analysis of macrophage-specific miR-155 expression, which was downregulated during macrophage differentiation (Figure 4A), showed that polarization of BMDMs into pro-inflammatory M1-type macrophages upon stimulation with LPS and IFN-γ (in contrast to antiinflammatory M2-type polarization induced by IL-4) induced m…”
InfluentialKanters, E., Pasparakis, M., Gijbels, M. J. J., Vergouwe, M. N., Partouns-Hendriks, I., Fijneman, R. J. A., Clausen, B. E., Förster, I., Kockx, M. M., Rajewsky, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18580 · Cited by 340
Chen, T., Huang, Z., Wang, L., Wang, Y., Wu, F., Meng, S., & Wang, C. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp121 · Cited by 298
Yang, K., He, Y. S., Wang, X. Q., Lu, L., Chen, Q. J., Liu, J., Sun, Z., & Shen, W. F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.009 · Cited by 257
IL-10 Inhibits miR-155 Induction by Toll-like Receptors
McCoy, C. E., Sheedy, F. J., Qualls, J. E., Doyle, S. L., Quinn, S. R., Murray, P. J., & O'Neill, L. A. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102111 · Cited by 256
Bcl-6 and NF-κB cistromes mediate opposing regulation of the innate immune response
Barish, G. D., Yu, R. T., Karunasiri, M., Ocampo, C. B., Dixon, J., Benner, C., Dent, A. L., Tangirala, R. K., & Evans, R. M. (2010) · Genes & Development · doi:10.1101/gad.1998010 · Cited by 256
Gatto, G., Rossi, A., Rossi, D., Kroening, S., Bonatti, S., & Mallardo, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn666 · Cited by 254
Interferon gamma: A master regulator of atherosclerosis
McLaren, J. E., & Ramji, D. P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.003 · Cited by 239
Zhou, Z., Subramanian, P., Sevilmis, G., Globke, B., Soehnlein, O., Karshovska, E., Megens, R., Heyll, K., Chun, J., Saulnier-Blache, J. S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.016 · Cited by 223
Self-citationRegulation of Lipid Droplet Cholesterol Efflux From Macrophage Foam Cells
Ouimet, M., & Marcel, Y. L. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.240705 · Cited by 221
Huang, R.-S., Hu, G.-Q., Lin, B., Lin, Z.-Y., & Sun, C.-C. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181ff46d7 · Cited by 190
MicroRNA function in myeloid biology
O’Connell, R. M., Zhao, J. L., & Rao, D. S. (2011) · Blood · doi:10.1182/blood-2011-03-291971 · Cited by 177
BCL-6 regulates chemokine gene transcription in macrophages
Toney, L. M., Cattoretti, G., Graf, J. A., Merghoub, T., Pandolfi, P.-P., Dalla-Favera, R., Ye, B. H., & Dent, A. L. (2000) · Nature Immunology · doi:10.1038/79749 · Cited by 171
Qi, J., Qiao, Y., Wang, P., Li, S., Zhao, W., & Gao, C. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.011 · Cited by 170
Ohlsson, B. G., Englund, M. C., Karlsson, A. L., Knutsen, E., Erixon, C., Skribeck, H., Liu, Y., Bondjers, G., & Wiklund, O. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118780 · Cited by 165
Ricote, M., Valledor, A. F., & Glass, C. K. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000103951.67680.b1 · Cited by 162
The genomic landscapes of inflammation
Natoli, G., Ghisletti, S., & Barozzi, I. (2011) · Genes & Development · doi:10.1101/gad.2018811 · Cited by 152
Donners, M. M. P. C., Wolfs, I. M. J., Stöger, J. L., van der Vorst, E. P. C., Pöttgens, C. C. H., Heymans, S. R. B., Schroen, B. L. M., Gijbels, M. J., & de Winther, M. P. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035877 · Cited by 147
MicroRNA-155 Is Required for Mycobacterium bovis BCG-Mediated Apoptosis of Macrophages
Ghorpade, D. S., Leyland, R., Kurowska-Stolarska, M., Patil, S. A., & Balaji, K. N. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06597-11 · Cited by 142
Necela, B. M., Su, W., & Thompson, E. A. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02849.x · Cited by 140
Koch, M., Mollenkopf, H., Klemm, U., & Meyer, T. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116125109 · Cited by 131
The Bcl6-SMRT/NCoR Cistrome Represses Inflammation to Attenuate Atherosclerosis
Barish, G. D., Yu, R. T., Karunasiri, M. S., Becerra, D., Kim, J., Tseng, T. W., Tai, L.-J., Leblanc, M., Diehl, C. J., Cerchietti, L. C. A., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.02.012 · Cited by 116
Denecke, B., Rostalsky, A., Hristov, M., Koeppel, T. A., Bidzhekov, K., Gan, L., Zernecke, A., & Weber, C. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-09-0607 · Cited by 114
Self-citationThe role of microRNAs in arterial remodelling
Nazari-Jahantigh, M., Wei, Y., & Schober, A. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-12-0826 · Cited by 112
Self-citationKanters, E., Gijbels, M. J., van der Made, I., Vergouwe, M. N., Heeringa, P., Kraal, G., Hofker, M. H., & de Winther, M. P. J. (2003) · Blood · doi:10.1182/blood-2003-05-1450 · Cited by 111
B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma
Ci, W., Polo, J. M., & Melnick, A. M. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328302c7df · Cited by 94
Toll-Like Receptor-4 and Lipoprotein Accumulation in Macrophages
Miller, Y. I., Choi, S.-H., Fang, L., & Harkewicz, R. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2010.02.001 · Cited by 72
Zhao, Y., van Berkel, T. J. C., & Eck, M. V. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833dedaa · Cited by 70
Hamilton, T. A., Major, J. A., & Chisolm, G. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117887 · Cited by 60
BCL-6 Negatively Regulates Expression of the NF-κB1 p105/p50 Subunit
Li, Z., Wang, X., Yu, R. Y.-L., Ding, B. B., Yu, J., Dai, X.-M., Naganuma, A., Stanley, E. R., & Ye, B. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.205 · Cited by 53
Regulation of cholesterol efflux from macrophages
Marcel, Y. L., Ouimet, M. I., & Wang, M. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830f4a1d · Cited by 48
BCL6 represses NFκB activity in diffuse large B‐cell lymphomas
Pérez‐Rosado, A., Artiga, M. J., Vargiu, P., Sánchez‐Aguilera, A., Alvarez, A. M., & Piris, M. A. (2008) · The Journal of Pathology · doi:10.1002/path.2279 · Cited by 41
Gremse, F., Grouls, C., Palmowski, M., Lammers, T., de Vries, A., Grüll, H., Das, M., Mühlenbruch, G., Akhtar, S., Schober, A., et al. (2011) · Radiology · doi:10.1148/radiol.11110069 · Cited by 36
Self-citationLi, Y., & Tabas, I. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806518 · Cited by 11
Cited by
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Locati, M., Curtale, G., & Mantovani, A. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012718 · Cited by 2,199
M2b macrophage polarization and its roles in diseases
Wang, L.-X., Zhang, S.-X., Wu, H.-J., Rong, X.-L., & Guo, J. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru1018-378rr · Cited by 884
Macrophage phenotypes in atherosclerosis
Colin, S., Chinetti‐Gbaguidi, G., & Staels, B. (2014) · Immunological Reviews · doi:10.1111/imr.12218 · Cited by 657
MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1
Schober, A., Nazari-Jahantigh, M., Wei, Y., Bidzhekov, K., Gremse, F., Grommes, J., Megens, R. T. A., Heyll, K., Noels, H., Hristov, M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3487 · Cited by 630
Self-citationMicroRNA Regulation of Atherosclerosis
Feinberg, M. W., & Moore, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306300 · Cited by 627
Metadata
- Authors
- Nazari-Jahantigh, M., Wei, Y., Noels, H., Akhtar, S., Zhou, Z., Koenen, R. R., Heyll, K., Gremse, F., Kiessling, F., Grommes, J., Weber, C., & Schober, A.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-08
- Volume
- 122
- Issue
- 11
- Pages
- 4190-4202
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2085185881
- Cited by
- 536
- References
- 61
- FWCI
- 16.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.